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Despite high interest in the cellular degradation machinery and protein degradation signals
(degrons), few degrons with universal activity along species have been identiﬁed. It has been shown
that fusion of a target protein with a degradation signal from mammalian ornithine decarboxylase
(ODC) induces fast proteasomal degradation of the chimera in both mammalian and yeast cells.
However, no degrons from yeast-encoded proteins capable to function in mammalian cells were
identiﬁed so far. Here, we demonstrate that the yeast transcription factor Rpn4 undergoes fast
proteasomal degradation and its central domain can destabilize green ﬂuorescent protein and
Alpha-fetoprotein in human HEK 293T cells. Furthermore, we conﬁrm the activity of this degron
in yeast. Thus, the Rpn4 central domain is an effective interspecies degradation signal.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The turnover of intracellular proteins is a tightly regulated and
constantly adjusted process, with the 26S proteasome complex as
one of the key players. In most cases, protein substrates are tagged
with ubiquitin (Ub) chains that are recognized by the 19S regula-
tory particle of the 26S proteasome. On the other hand, increasing
numbers of proteins are shown to be degraded by the proteasome
without prior ubiquitination [4]. Among these: ornithine decar-
boxylase (ODC), thymidylate synthase, yeast Rpn4, c-jun, p-21
and others [15,10,8,18]. Furthermore, it is estimated that up to
22% of all cellular proteins undergo proteasome-dependent prote-
olysis when omitting ubiquitination [3]. Special motifs denoted as
degradation signals (degrons) are responsible for ubiquitin-depen-
dent and ubiquitin-independent degradation [28]. Ubiquitin-
dependent degrons consist of a preferential ubiquitination site
(mostly lysine) and a distinct sequence. Conversely, ubiquitin-
independent degradation signals frequently share structural,
rather than sequence, similarities. They contain an intrinsically
disordered region and an alpha helix, which serve two major
functions: the initiation of degradation and tethering to the protea-
some, respectively [17,21]. Little is known about interspeciesdegrons and the evolution of the degradation machinery from
lower to higher eukaryotes. The rare example, except classical
N-degrons [25], is the mammalian ODC degron, which promotes
the degradation of chimeric proteins in mammalian and yeast
cells [5,23,11,19]. However, no yeast-derived, degradation signals,
capable to work in mammalian cells have been discovered. Yeast
protein Rpn4 (yRpn4) is a transcription factor with extremely short
half-life (1–2 min). It controls proteasome abundance through a
negative feedback mechanism [16,27]. Turnover of yRpn4 plays
an important role in the resistance to various stresses [26,12]
and is tightly regulated. It was shown that degradation of yRpn4
can be both Ub-dependent and -independent [10]. The N-terminal
portion of yRpn4 (a.a. 1–80) contains a portable Ub-independent
degron with an intrinsically disordered domain and a folded
segment [7] (Fig. 1A and Suppl. Fig. 1A). This degron mediates
the cotranslational degradation of yRpn4 [6]. Portable ubiquitin-
dependent degron of yRpn4 was mapped to 172–229 a.a. [9]. It
contains the preferable polyubiquitination site K187 and proximal
acidic domain that mediates the interaction with the cognate
ubiquitin ligase Ubr2 [9] (Fig. 1A).
Given that yRpn4 degradation is mediated by the evolutionarily
conservative components of the ubiquitin–proteasome system, we
suggested that yRpn4 could be highly unstable in higher eukaryotic
cells and contain degrons capable of promoting chimeric protein
degradation in mammalian cells. In this study, we demonstrated
that human proteasomes effectively degrade yRpn4 as well as
two different stable proteins fused to the central domain of
yRpn4.
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Fig. 1. Recombinant yRpn4 accumulates in transfected HEK 293T cells after
treatment with proteasome inhibitor. Schematic representation of yRpn4 degrons
(A). Lysine 187 is marked. (B) Proteasome inhibition assay. Western blot analysis of
lysates of transfected 293T cells. Cells were maintained in growth media containing
no proteasome inhibitor (track 1), 10 lMMG132 or 10 lM lactacystin (tracks 2 and
3 respectively). yRpn4 was detected by Western blotting with anti-yRpn4
antibodies. Equal protein loading was conﬁrmed by staining the membrane with
anti-b-actin antibodies. yRpn4 and b-actin are marked by arrow heads.
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2.1. Cell lines
The human embryonic kidney cell line HEK 293T (ATCC
CRL-3216) was used for transfection. Cells were maintained in
Dulbecco’s modiﬁed Eagle medium (DMEM) supplemented with
10% fetal bovine serum, L-glutamine and antibiotics (all from
PanEco, Russia) and kept at 37 C, 5% CO2 and 95% humidity.
2.2. Vectors
Using the pEGFP-N1 (Clontech, USA) backbone, two eukaryotic
expression vectors encoding the yRpn4 and GFP-ODC degradation
signal chimera were designed. The RPN4 gene and mouse ODC deg-
radation signal were cloned from previously obtained plasmids
[13,19], and the constructs were denoted pyRpn4 and pGFP-ODC-
signal. The design of additional control vectors pDAFP (encoding
murine Alpha-fetoprotein (AFP) without leader sequence) and
pDAFPODCsignal (encoding murine Alpha-fetoprotein without
leader sequence and carrying ODC degron) is described elsewhere
[20,19]. The leader sequence was removed in order to ensure
cytoplasmic localization of the recombinant proteins.
Plasmids pyRpn4(1–82)-N-GFP, pyRpn4(1–110)-N-GFP, pyR-
pn4(1–176)-N-GFP, pyRpn4(172–229)-N-GFP, pyRpn4(177–327)-
N-GFP and pyRpn4(230–327)-N-GFP were obtained by cloning
in-frame RPN4 gene fragments encoding yRpn4 portions (the cor-
responding amino acids are indicated in brackets) upstream of
the GFP gene in pEGFP-N1. Plasmids pGFP-C-yRpn4(1–82), pGFP-
C-yRpn4(1–110), and pGFP-C-yRpn4(172–229) were obtained by
cloning the RPN4 fragments downstream of the GFP gene in
pEGFP-N1. Plasmid pyRpn4(177–327)-N-DAFP was derived frompDAFP by cloning RPN4 gene fragment upstream of the DAFP gene.
The constructs were veriﬁed by restriction analysis and sequenc-
ing. Plasmids were ampliﬁed in DH5a cells and isolated using
the Qiagen Plasmid Mini kit (Qiagen, Germany). All proteins
encoded by these vectors bore a stabilizing amino acid at their
N-termini next to methionine to avoid degradation by the N-termi-
nal rule.
2.3. Transfection and preparation of cellular lysates
HEK 293T cells (3  105) were transfected with 1 lg of plasmids
using Mirus TransIT-293 reagent (Mirus Bio, USA) according to the
manufacturer’s instructions. 48 h post transfection cells were ﬁrst
examined under a DMI 4000B ﬂuorescent microscope (Leica, Ger-
many) and then washed, scraped and analyzed by ﬂow cytometry
or lysed in NP-40 buffer (Tris–HCl, pH 8.0 50 mM, NaCl 150 mM,
NP-40 1%, EDTA 5 mM, containing protease inhibitor cocktail
(Roche, Germany)). Lysates were collected and stored at 80 C
before use.
2.4. SDS PAGE and Western blotting
Proteins were separated in 10% or 13% Tris–Glycine polyacryl-
amide gels followed by transfer onto nitrocellulose membranes
(BioRad, USA). The GFP and GFP-yRpn4 chimeras were detected
using polyclonal rabbit anti-GFP antibodies (Abcam, USA) taken
1:1000 or mouse monoclonal anti-GFP antibodies taken 1:1000
(ProteinSynthesis, Russia) and goat anti-mouse, or anti-rabbit
HRP conjugated antibodies, both were used 1:20,000 (Enzo, USA
and Abcam, USA respectively). AFP was detected using polyclonal
rabbit anti-AFP antibodies diluted 1:1000 and goat anti-rabbit
HRP conjugates (both from Abcam, USA). To stain yRpn4, we used
rabbit anti-yRpn4 antibodies [14]. Ubiquitin was revealed using
rabbit anti-Ub antibodies taken 1:1000 (Abcam, USA). The blots
were detected using ECL kit (GE Healthcare, UK). To ensure equal
loading of protein in each lane, the membranes were stripped
and stained with anti-b-actin antibodies diluted from 1:1000 to
1:2000 (Sigma–Aldrich, Germany).
2.5. Proteasome inhibition assay with MG132/lactacystin and
cycloheximide/puromycin chase
Thirty hours post transfection, HEK 293T cells were treated with
10 lM MG132/lactacystin (both from Sigma–Aldrich, Germany)
and incubated for 18 h at 37 C. Treated cells were then examined
using a DMI 4000B ﬂuorescent microscope (Leica, Germany), after
that, samples were investigated by ﬂow cytometry or lysed and
analyzed by Western blotting.
The translation inhibitors cycloheximide (CHX, Sigma–Aldrich,
Germany) and puromycin (Sigma–Aldrich, Germany) were used
to evaluate the kinetics of recombinant protein degradation; 48 h
post transfection, HEK 293T cells were treated with 100 lg/ml
(ﬁnal concentration) cycloheximide or 10 lg/ml puromycin.
Immediately after treatment and after 2, 4 and 6 h of incubation
with the translation inhibitors, the cells were scraped and lysed,
and the cellular lysates were analyzed by Western blotting. Exper-
iments were performed twice.
2.6. Accumulation chase
Forty-eight hours post transfection, the cell culture media was
supplemented with MG132 (10 lM); and after incubation for 2, 4
and 6 h, the cells were lysed and analyzed for recombinant
protein accumulation by Western blotting. The signals were
normalized by staining the membrane with anti-b-actin antibodies
(Sigma–Aldrich, Germany). X-ray ﬁlms with the detected bands
A.V. Morozov et al. / FEBS Letters 588 (2014) 3713–3719 3715were analyzed using ImageJ software (for reference http://
www.di.uq.edu.au/sparqimagejblots can be used). In brief, rectan-
gular sections were placed over the detected protein bands; histo-
grams indicating the intensity of each of the bands were obtained;
the peaks were separated from the background and the peak area
value indicating the intensity of the band was calculated. To nor-
malize signal intensities the same was performed with the b-actin
bands. Relative protein band intensity values were multiplied on
the coefﬁcients derived from b-actin band measurements. Finally,
the normalized signal intensity values were used to build accumu-
lation curves using Microsoft Excel. The method is further
described in the results.
2.7. Immunoprecipitation
Protein-G-agarose slurry (Millipore, USA) was inactivated with
bovine serum albumin in PBS at RT with shaking. Mouse monoclo-
nal anti-GFP antibodies (ProteinSynthesis, Russia) (1:200) were
incubated with cell lysates at 10 C during 2 h. 20 ll of 50% BSA
inactivated Protein-G-agarose slurry was added to each mixture
and incubation was prolonged for 1.5 h at 10 C. Slurries were
washed once with 20 volumes of ice-cold PBS and twice with 20
volumes of PBS with 0.1% Tween. Immunocomplexes were eluted42 kDa
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3. Results and discussion
3.1. yRpn4 is degraded by proteasomes of higher eukaryotes
To assess the stability of yRpn4 in human cells, HEK 293T cells
were transfected with the plasmid expressing yRpn4 under control
of the cytomegalovirus (CMV) promoter, and the yRpn4 level was
measured by Western blotting. Under normal conditions, we were
unable to detect yRpn4. However, the protein band corresponding
to yRpn4 was clearly observed when cells were treated with
MG132 or lactacystin. Our results highlight the involvement of
human proteasomes in the fast turnover of yRpn4 (Fig. 1B). To
evaluate the rate of yRpn4 hydrolysis in HEK 293T cells, we per-
formed a cycloheximide chase. However, we failed to assess the
yRpn4 degradation kinetics due to the extremely low level of
yRpn4 in the cells incubated without proteasome inhibitors (data
not shown).
To solve this problem, we designed an experiment to estimate
yRpn4 degradation by monitoring its accumulation and called it
an accumulation chase. To build reference accumulation curves,P
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tein lacking export signal (DAFP) and green ﬂuorescent protein
(GFP), and unstable chimeric proteins, GFP and DAFP fused to the
ODC degron (GFP-ODCsignal and DAFPODCsignal respectively). It
should be noted that, in the presence of a proteasome inhibitor,
CMV-driven transcription could be stimulated and contribute to
protein accumulation [1]. To account for this effect, all proteins
were expressed from vectors where genes of interest were under
control of identical CMV promoters. Using a proteasome inhibition
assay and cycloheximide chase, we conﬁrmed the slow degrada-
tion kinetics of GFP and DAFP and fast proteasomal hydrolysis of
GFP-ODCsignal and DAFPODCsignal (both half-lives approximately
3 h) in transfected cells (Fig. 2A). Interestingly, in the accumulation
chase, we observed accumulation with the constant rate of stable
GFP and DAFP for 6 h (Fig. 2A and B). In contrast, unstable GFP-
ODCsignal DAFPODCsignal accumulated rapidly within 2 h after
the addition of MG132 followed by a much slower rate of accumu-
lation. The initial brisk accumulation of fast-degrading proteins
may be explained as an effect of proteasome inhibition. The subse-
quent slow rate of accumulation likely represents partial revers-
ibility of inhibition and enhancement of proteasome activity due
to a negative feedback mechanism of proteasome regulation [27].
We have shown that the accumulation kinetics of yRpn4 is closer
to that of the fast-degrading GFP-ODCsignal and DAFPODCsignal
(Fig. 2B and C). Therefore, we can conclude that yRpn4 is an unsta-
ble protein and a proteasome substrate in human cells.GFP
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cells expressing yRpn4 fragments as N-terminal or C-terminal fusions of GFP (B) and (C),
constructs (left and middle panels). Cells were analyzed by ﬂuorescent microscopy. G
Presence (+) or absence () of proteasome inhibitor MG132 in the transfected cell cultur
cycloheximide chase (right panels). Recombinant proteins and b-actin are indicated by3.2. N-terminal degron of yRpn4 does not induce proteasomal
degradation of the yRpn4-GFP chimera in HEK 293T cells
It was shown that the ﬁrst 80 N-terminal amino acids of yRpn4
comprise a portable ubiquitin-independent degron in yeast [7]
(Fig. 1A). To estimate its activity in HEK 293T cells, we analyzed
the stability of chimeras containing N-terminal fragments of yRpn4
fused to a reporter protein (GFP) using a proteasome inhibition
assay, cycloheximide chase, ﬂuorescent imaging and ﬂow cytome-
try. First, we again conﬁrmed the stability of wild type GFP
(Fig. 3A). Next, we found that administration of MG132 into the
culture growth media of transfected cells only slightly inﬂuenced
the yRpn4(1–82)-N-GFP and GFP-C-yRpn4(1–82) levels (Fig. 3B
and C). These chimeras were also stable in the cycloheximide chase
(Fig. 3B and C). These data suggest that the N-degron is likely inac-
tive in HEK 293T cells. Bioinformatic analysis of yRpn4 identiﬁed a
potential PEST signal downstream of the N-terminal degron at a.a
88–110 (Suppl. Fig. 1A and B). To check its activity, we analyzed
the stability of yRpn4(1–110)-N-GFP and GFP-C-yRpn4(1–110).
We observed a stronger effect of MG132 on the accumulation of
GFP-C-yRpn4(1–110) in transfected cells; however, both chimeras
were again stable in the cycloheximide chase (Fig. 3B and C).
It has been shown that the addition of cycloheximide into cell
culture media prevented heterologously expressed IgM heavy
chains from ER-associated degradation, while another translation
inhibitor, puromycin, did not [2]. In this regard, we investigated0     2     4    6 Hours 
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puromycin and conﬁrmed the stability of the chimeric protein
(Suppl. Fig. 2).
The observed limited accumulation of yRpn4-GFP fusion pro-
teins after the addition of MG132 may be explained by enhanced
expression from the CMV promoter [1]. Indeed, RT-PCR showed
that the mRNA levels of wild type yRpn4 and all of the four chime-
ras were slightly increased (Suppl. Fig. 3A and B). Therefore, we
suggest only a minor inﬂuence of the N-degron and PEST-motif
on GFP degradation in HEK 293T cells.
To identify other potential degrons in the N-terminal domain of
yRpn4, we analyzed the stability of yRpn4(1–176)-N-GFP. Using a
proteasome inhibition assay, ﬂuorescent imaging and ﬂow
cytometry, we demonstrated that the chimeric protein was nearly
undetectable in transfected cells (Fig. 3B, Suppl. Figs. 4 and 5). In
inhibitor-free conditions, only 12% of cells were conﬁrmed positive
by ﬂow cytometry, compared to 81% for wild type GFP. After the
addition of MG132, 27% of cells transfected with yRpn4(1–176)-
N-GFP were slightly above the threshold, in contrast to 85% for
GFP (Suppl. Fig. 4). Moreover, the amount of yRpn4(1–176)-N-
GFP in transfected cell lysates was marginally increased after the
administration of proteasome inhibitors (Fig. 3B, Suppl. Fig. 5).
Interestingly, the levels of yRpn4(1–176)-N-GFP mRNA were
extremely low (Suppl. Fig. 3B).
Thus, we suggest that the N-terminal domain of yRpn4 does not
contain degradation signals capable of stimulating hydrolysis of
chimeric proteins in human cells.3.3. The central domain of yRpn4 stimulates fast degradation of GFP
and AFP
Next, we examined the central portion of yRpn4. It was shown
that the yRpn4 fragment a.a. 172–229 is a portable, ubiquitin-
dependent degron in yeast [9]. To evaluate its activity, we fused
it to GFP making the N-terminal and C-terminal fusions. The HEK
293T cells transfected with the corresponding constructs were
subjected to a proteasome inhibition assay. After treatment with
MG132, we observed insigniﬁcant increase in GFP ﬂuorescence in
transfected cells (Fig. 4A and B). Moreover, the chimeras were also
stable during the 6 h cycloheximide chase (Fig. 4A and B). These
data indicate that the ubiquitin-dependent degron of yRpn4 is inef-
fective in cells of higher eukaryotes.
To search for other potential degrons in the central part of
yRpn4, we analyzed the stability of yRpn4(177–327)-N-GFP. Trans-
fected HEK 293T cells displayed signiﬁcantly increased GFP ﬂuores-
cence after MG132 treatment (Fig. 4A, Suppl Fig. 4), and analysis of
cellular lysates by Western blotting suggested proteasome-depen-
dent degradation of yRpn4(177–327)-N-GFP (Fig. 4A). These results
were further conﬁrmed using another proteasome inhibitor, lacta-
cystin (Suppl. Fig. 5). Moreover, cycloheximide chase experiments
showed that the half-life of yRpn4(177–327)-N-GFP was 1–1.5 h,
which was in average 2 times lower than that of GFP-ODCsignal
(half-life 2–2.5 h) (the experiments were performed twice)
(Fig. 4A and C). Therefore, we suggest that the central domain of
yRpn4 contains efﬁcient degradation signal(s). Using previously
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methylase as a reporter protein and conﬁrmed that the yRpn4
fragment a.a. 177–327 represents a transferable degron in yeast
(Suppl. Fig. 6).
In addition we performed immunoprecipitation of recombinant
GFP, yRpn4(177–327)-N-GFP from transfected cellular lysates with
anti-GFP immunoglobulins. No precipitated proteins were
detected as shown by Western blot with anti-Ub antibodies
(Fig. 5A).
Further on we studied the degradation of a truncated fusion
protein bearing (a.a 230–327) fragment of the central part of
yRpn4 fused with GFP. By ﬂuorescent microscopy, proteasome
inhibition assay and cycloheximide chase it was shown that the
chimera is stable and undergoes slow degradation in HEK 293T
cells (Fig. 4A). Interestingly, besides expected 37 kDa protein we
observed two larger proteins of 42 and 50 kDa. These forms may
represent proteins with different modiﬁcations such as ubiquitina-
tion or sumoylation, however it was not further investigated.
Furthermore, Dam methylase activity test conﬁrmed that the a.a
230–327 is a weak degron in yeast (Suppl. Fig. 6). Obtained data
are in favor of the fact that the central domain of yRpn4 may rep-
resent a conformational degron. However, one can not exclude that
central domain of yRpn4 contains two degrons: previously identi-
ﬁed Ub-dependent that works in yeast, but doesn’t work in human
cells and a conformational degron which is capable to induce deg-
radation at least in mammalian cells and likely in yeast.
Finally, to test if the elucidated part (a.a. 177–327) of the yRpn4
can serve as an effective interspecies degron, capable to destabilize
different proteins we fused it with DAFP. The proteasome
inhibition assay and the cycloheximide chase were performed on
transfected HEK 293T cells. In the presence of MG132 the drastic
increase of recombinant yRpn4(177–327)-N-DAFP in the cellularlysate was demonstrated by Western blotting (Fig. 5B). Using
cycloheximide chase half-life of the recombinant protein was
estimated 2–3 h, suggesting efﬁcient degradation.
4. Conclusions
Degradation of the yeast transcription factor yRpn4 in human
cells was investigated. It was found that yRpn4 expressed in trans-
fected HEK 293T cells undergoes fast proteasomal degradation.
Interestingly, N-terminal ubiquitin-independent degron of yRpn4
that was shown to function in yeast cells was incapable to promote
the degradation of chimeric proteins in human cells. However, the
central domain of yRpn4, which contains an ubiquitin-dependent
degron effectively induced the degradation of GFP. Notably, fusion
of the sole yRpn4 ubiquitin-dependent degron to the C- or N-ter-
mini was insufﬁcient to destabilize the substrate. Accordingly,
using immunoprecipitation with anti-GFP antibodies we detected
no ubiquitinated proteins in yRpn4(177–327)-GFP transfected cel-
lular lysates even though cells were treated with MG132. Thus,
indicating that other structures in the central part of yRpn4 are
important for proteosomal degradation in HEK 293T cells. More-
over, using Dam methylase assay we obtained evidence that
yRpn4(177–327) can serve as a degron in yeast. Finally, we demon-
strated that another recombinant protein carrying this degron
yRpn4(177–327)-DAFP is rapidly hydrolyzed by the human pro-
teasomes. Therefore, the central domain of yRpn4 might be consid-
ered as an efﬁcient interspecies degradation signal. Key elements
inside this part of yRpn4 responsible for degradation have yet to
be elucidated. In general, the identiﬁcation of generic structures
that are essential for protein degradation can be beneﬁcial for a
variety of applications, including in therapies when artiﬁcial pro-
teasome targeting of a speciﬁc protein is necessary. In this regard,
A.V. Morozov et al. / FEBS Letters 588 (2014) 3713–3719 3719yeast degradation signals could be more favorable to mammalian
degrons, such as that of ODC, due to a reduced risk of autoimmune
reactions. Finally, future investigations of degradation signals
could deepen our understanding of common principles of protein
degradation that are shared by lower and higher eukaryotes.
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